Eye

Galimedix Therapeutics announced the initiation of its phase 2 eDREAM study to assess the safety and efficacy of GAL-101 eye drops in patients with dry age-related macular degeneration, according to a company press release.

INDIANAPOLIS — The blue-green appearance of the Acuvue Oasys Max 1-day contact lens made it easier to see and may improve handling, especially among presbyopic patients, according to a poster presented at Academy 2024.

INDIANAPOLIS — Alcon announced the launch of Precision7, a 1-week replacement contact lens containing a new technology that provides up to 16 hours of comfort and precise vision in both sphere and toric designs, at Academy 2024.

LAS VEGAS — Fifty-two percent of American consumers surveyed said a “Made in the USA” label is an important factor in their purchasing decisions, according to a report from the Vision Council.

Bausch + Lomb has announced that its Soothe antibiotic drops have been approved by Health Canada for over-the-counter use in the treatment of external infections of the eye and ear, according to a company press release.

Scope Health announced its acquisition of Eyetamins, an eye health supplement brand created by neuro-ophthalmologist Kaushal Kulkarni, MD, according to a press release.

Clobetasol propionate ophthalmic suspension 0.05% for postoperative inflammation and pain after ocular surgery is now commercially available in the U.S., according to a press release from Eyenovia.

LAS VEGAS — CSI Dry Eye Software has launched new technology that uses AI to assist clinicians in making a dry eye diagnosis and developing a treatment plan, according to a company executive at Vision Expo West.

In this Healio video, Jacquie M. Bowen, OD, president-elect of the American Optometric Association, discusses the AOA’s recent consumer alert about over-the-counter color-changing eye drops.